Luminous fish effect – Big Bang Theory

Do you think this would take off?http://bigbangtheory.wikia.com/wiki/The_Luminous_Fish_Effect

Follow me on: Facebook "Fin Page" – YouTube – Blog – Linkedin – Twitter

—
Yours sincerely,

Dr Richmond Loh DipProjMgt, BSc, BVMS, MPhil (Pathology) Murdoch, MANZCVS (Aquatics & Pathobiology).
Veterinarian | Adjunct Lecturer Murdoch University | President-elect WAVMA |
Secretary Aquatic Animal Health Chapter – ANZCVS.
The Fish Vet, Perth, Western Australia, AUSTRALIA. Mobile Veterinary Medical & Diagnostic Services for fish and other aquatic creatures.
http://www.thefishvet.com.au
Ph: +61 (0)421 822 383

Looking for more books? Check out this site.

FDA offering grants for research into drugs for use in minor species (namely aquacultured fishes).

Grants (and workshops on the process) such as these would be useful if it was available in Australia.

 

 

———- Forwarded message ———-
From: Dr. David Scarfe <DScarfe@avma.org>
Date: Wed, Jun 12, 2013 at 5:27 AM
Subject: AquaVetMed e-News: FDA 2013 MUMS Grant Applications – Close Aug 16.
To:

June 11, 2013

FDA Announces Minor Use/Minor Species (MUMS) Grant Program Request for Applications Open Period due August 16, 2013

 

The Food and Drug Administration today announced the opening date for applications for grants to support the development of new animal drugs intended for minor species or minor uses in major species. (Major species are horses, dogs, cats, cattle, pigs, turkeys and chickens.) Applications are due electronically by August 16, 2013 at www.grants.gov.

 

The grant program was established by the Minor Use and Minor Species Animal Health Act of 2004, and funding was authorized to start after finalization of regulations to implement the Designation provisions of Section 573 of the Federal Food, Drug & Cosmetic Act.

 

Eligibility requirements to apply for a MUMS grant include:

  • ·        the drug must be ‘designated’ by the Center for Veterinary Medicine’s (CVM) Office of Minor Use and Minor Species Animal Drug Development (OMUMS) under the MUMS Act;
  • ·        the grant funding must be used to defray the costs of qualified safety and effectiveness testing expenses associated with the development of the drug for the designated intended use;
  • ·        interested parties must have a study protocol that has been accepted by CVM’s Office of New Animal Drug Evaluation (ONADE) prior to submitting the grant application.

 

Qualified safety studies include those intended to support target animal safety, environmental safety, and human food safety. For human food safety, a separate study to validate an analytical method prior to conduct of an in-life study is eligible for funding, if a protocol for the stand-alone method validation study has been accepted by ONADE.

 

Grants will be available for up to $75,000 per year for up to two years for routine studies; and up to $125,000 per year for up to two years for studies of unusual complexity, duration or size. A third year of funding may be available for long-term toxicology studies. Therefore, grants could range from under $75,000 for a routine study that could be completed in less than a year, to $250,000 for a complex study requiring two years for completion, to $375,000 for a long-term toxicology study. Indirect costs are limited to 15% of direct costs.

 

The complete Request for Applications is available at http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-12-003.html. Please note revisions to dates and text in Notice NOT-FD-13-014, at http://grants.nih.gov/grants/guide/notice-files/NOT-FD-13-014.html.

___________________________

AquaVetMed e-News provides information to veterinary and veterinary-allied subscribers concerning aquatic animal medicine, health, welfare, public health and seafood safety, obtained from a variety of sources (largely AquaVetMed subscribers). While provided by the American Veterinary Medical Association’s, Aquatic Veterinary Medicine Committee and are for public distribution, they do not necessarily reflect the opinion of the AVMA or the veterinary profession. See the AVMA Terms of Use (http://tinyurl.com/29h2rf) for further information.

 

If e-News information is used elsewhere please acknowledge AquaVetMed as the source.  Encourage individuals to subscribe rather than distribute through list serves.

 

Messages may contain attachments that will have been scanned for known viruses.

 

Subscription and Contributions: Interested veterinarians and veterinary-allied professionals can subscribe, unsubscribe, or contribute pertinent news or information, by sending a message with “For AquaVetMed -” and the topic in the subject line, to dscarfe@avma.org.

 

Note: Undelivered e-mails will not be resent; Subscribers will be deleted from the list after repeated undelivered or bounced messages and will have to re-subscribe.

 

Visit our website: www.avma.org

 

________________________________

 

 

Current & New Approaches for Animal Drugs in Feeds: On-line presentations available to view.

This will be useful.

 
———- Forwarded message ———-
From: Dr. David Scarfe <DScarfe@avma.org>
Date: Thu, Jun 6, 2013 at 8:58 PM

Regulations involving how drugs are delivered through medicated feed in the US are undergoing major advances. To convey the information to the widest audience available, the presentations of a 2-day New Animal Drugs for Use in Feeds Workshop (which was on May 22-13, 2013) have now been made available on-line.

 

Intended to cover the approval process for medicated animal feeds, government agencies involved, on how medicated feeds should be used, different types of medicated feeds, labels and how medicated feeds should be used, changes in veterinary feed directives, judicious use and changes of over-the-counter (OTC) availability of antimicrobial drugs, and a number of other important issues are outlined in the following presentations.

 

• Medicated Feed Workshop Introduction, Logistics – Bernadette Dunham, FDA-CVM

• Introducing the Center for Veterinary Medicine: Organization and Structure – Sanja Modric, FDA-CVM

• New Animal Drugs for Use in Animal Feeds: Types and Categories – Dragan Momcilovic, FDA-CVM

• Development and Approval of Labeling for Medicated Feeds – Suzanne Sechen, FDA-CVM

• Where to Find Approved Labeling for Medicated Feed – Dragan Momcilovic and Suzanne Sechen, FDA-CVM

• Proposed Changes: Veterinary Feed Directive – Jo Gulley and Sharon Benz, FDA-CVM

• Antimicrobial Drugs in Animal Feeds: Update on FDA’s Judicious Use Strategy – Craig Lewis, FDA-CVM

• Understanding ADAA Combinations – Dan Benz, FDA-CVM

• Generic Approval Process and Biowaiver Requirements – Charli Long, FDA-CVM

• Biomass Drug Substances – Amy Simms, FDA-CVM

• Type A Medicated Articles and CMC Issues – James Nitao, FDA-CVM

• CMC Data to Support Medicated Feeds – Heather Longstaff, FDA-CVM

• Medicated Feed Assay Methods and Limits: Regulatory Perspective – Asif Rasheed, FDA-CVM

• CMC Question & Answer

• What Do Feed Mill Inspections Have to Do with Drug Approvals? – Shannon Jordre, FDA-CVM

• Interactions with CVM – Cory Herr, Elanco, Keith Baker and Paul Duquette

• Round Table Discussion

• Wrap Up and Next Steps

 

To view one or more of these presentations go to http://tinyurl.com/lsofm7b.

___________________________

AquaVetMed e-News provides information to veterinary and veterinary-allied subscribers concerning aquatic animal medicine, health, welfare, public health and seafood safety, obtained from a variety of sources (largely AquaVetMed subscribers). While provided by the American Veterinary Medical Association’s, Aquatic Veterinary Medicine Committee and are for public distribution, they do not necessarily reflect the opinion of the AVMA or the veterinary profession. See the AVMA Terms of Use (http://tinyurl.com/29h2rf) for further information.

 

If e-News information is used elsewhere please acknowledge AquaVetMed as the source. Encourage individuals to subscribe rather than distribute through list serves.

 

Messages may contain attachments that will have been scanned for known viruses.

 

Subscription and Contributions: Interested veterinarians and veterinary-allied professionals can subscribe, unsubscribe, or contribute pertinent news or information, by sending a message with “For AquaVetMed -” and the topic in the subject line, to dscarfe@avma.org.

 

Note: Undelivered e-mails will not be resent; Subscribers will be deleted from the list after repeated undelivered or bounced messages and will have to re-subscribe.

 

Visit our website: www.avma.org

 

________________________________

 

 

Can it really rain fish and frogs?

Tornadoes, when they occur over water and with sufficient velocity, can create a ‘water spout’. This vortex can suck up water and the organisms within the water, carry it up to 100 miles. When the winds for down, the water and fish it carried will then drop from the sky!

I saw this on The Weather Channel.

20130603-010522.jpg

The truth about Animal Planet’s show on Mermaids.

Dr Starling from Aqueterinary Services from the US shared with me this video.

Link to CNN video.

But having visited Disney’s Hollywood, Magic Kingdom and EPCOT recently, there’s something to be said about having an imagination. I still like to hope that there could be such a thing as a mermaid. What about you?

Tricaine Pharmaq (formerly PHARMAQ MS 222) now marketing in the United Kingdom, Ireland, Norway, Iceland, The Faroe Islands, Spain and Italy.

This would have to be one of the safest, most reliable fish anaesthetic available. Hope it’ll become more freely available worldwide.

Begin forwarded message:

From: “Dr. David Scarfe”
Date: 29 May 2013 10:48:03 EDT
Subject: AquaVetMed e-News: Multi-country approval for fish anaesthetic, Tricaine Pharmaq

May 29, 2013
Marketing authorization for fish anaesthetic, Tricaine Pharmaq, in seven different countries

Press Release – In the past few months PHARMAQ has received national marketing authorisations for Tricaine Pharmaq for the United Kingdom, Ireland, Norway, Iceland, The Faroe Islands, Spain and Italy.

“Appropriate anaesthesia can provide benefits for a wide range of fish handling operations, helping to safeguard fish welfare and also improving operator safety during processes such as vaccination”, says Dr. Ben North, Managing Director of PHARMAQ Ltd.

Tricaine Pharmaq will replace the former product PHARMAQ MS 222, a compound well known to the industry and which held marketing authorisations in the UK and Ireland for many years. The formulation of the product remains the same (100% active tricaine methanesulphonate) and is available by prescription. Tricaine Pharmaq is readily soluble in water, making it safe and easy to use, with no requirement for solvents. Tricaine Pharmaq can benefit all sectors of the aquatic industry, from tranquilisation of ornamental fish during transport, through to full anaesthesia for surgical procedures, as well as anaesthesia of food fish at vaccination and egg collection from brood fish.

PHARMAQ UK will be the distribution centre for all of the different markets. Tricaine Pharmaq will be available in four different pack sizes from 25 g to 1000 g, all with separate national labels and inserts. “This is a great opportunity for PHARMAQ to introduce an established, safe and efficacious anaesthetic to support our customers in more of the markets where our fish vaccines are already being used”, added Dr. North

For further information, please contact:
Ben North Managing Director, PHARMAQ Ltd
Email ben.north@pharmaq.no
Tel: +44(0) 1425 651927
Mobile +44(0) 7900 195046

[For more information on this and other Pharmaq products, see http://www.pharmaq.no. ADS-Mod.]
___________________________
AquaVetMed e-News provides information to veterinary and veterinary-allied subscribers concerning aquatic animal medicine, health, welfare, public health and seafood safety, obtained from a variety of sources (largely AquaVetMed subscribers). While provided by the American Veterinary Medical Association’s, Aquatic Veterinary Medicine Committee and are for public distribution, they do not necessarily reflect the opinion of the AVMA or the veterinary profession. See the AVMA Terms of Use (http://tinyurl.com/29h2rf) for further information.

If e-News information is used elsewhere please acknowledge AquaVetMed as the source. Encourage individuals to subscribe rather than distribute through list serves.

Messages may contain attachments that will have been scanned for known viruses.

Subscription and Contributions: Interested veterinarians and veterinary-allied professionals can subscribe, unsubscribe, or contribute pertinent news or information, by sending a message with “For AquaVetMed -” and the topic in the subject line, to dscarfe@avma.org.

Note: Undelivered e-mails will not be resent; Subscribers will be deleted from the list after repeated undelivered or bounced messages and will have to re-subscribe.

Visit our website: http://www.avma.org

________________________________

Aquaponics Webinar: Paradigm Shift with Airlift.

From: Hawaii Aqua
Date: 29 May 2013 5:48:44 EDT
To: undisclosed-recipients:;
Subject: Fwd: June 30 webinar on airlift water pump

———- Forwarded message ———-
From: Ronald Weidenbach
Date: Tue, May 28, 2013 at 11:48 AM
Subject: HAAA Member News to Use: June 30 webinar on airlift water pump
To: Hawaii Aqua

Dear HAAA members,

The eXtension Freshwater Aquaculture Community of Practice (CoP) will
be presenting a webinar on aquaponics. Those that have a background in
aquaponics, please feel free to join the session and discussion.

The title of the webinar is:

Aquaponics: Paradigm Shift with Airlift

Presented by: Tetsuzan Benny Ron
May 30th, 2013 at 4PM Eastern/3PM Central

This will be a 1-hour presentation on aquaponics with a question and
answer session.

With thoughtful design, appropriate maintenance, and effective
management, airlift pumps may allow us to transfer water through an
aquaponics system in a more efficient way compared to that of water
pumps. Understanding the disadvantages and learning how easy it is to
construct an airlift pump can help many to reduce their energy
expenses while avoiding the risk and maintenance resulted from having
electrical pumps in the water.

To connect to the webinar, follow the link below:

https://connect.extension.iastate.edu/freshwater

For more information, please contact Vanessa Weldon at:vmaxwell24@gmail.com

https://learn.extension.org/events/1064

Check out pictures of Dr Loh’s adventures in the USA.

Will this inspire you to look after our aquatic environment even more?
https://www.facebook.com/thefishvetdrloh/photos_albums

Follow me on: Facebook "Fin Page" – YouTube – Blog – Linkedin – Twitter

—
Yours sincerely,

Dr Richmond Loh DipProjMgt, BSc, BVMS, MPhil (Pathology) Murdoch, MANZCVS (Aquatics & Pathobiology).
Veterinarian | Adjunct Lecturer Murdoch University | President-elect WAVMA |
Secretary Aquatic Animal Health Chapter – ANZCVS.
The Fish Vet, Perth, Western Australia, AUSTRALIA. Mobile Veterinary Medical & Diagnostic Services for fish and other aquatic creatures.
http://www.thefishvet.com.au
Ph: +61 (0)421 822 383

Looking for more books? Check out this site.